Equinix Inc vs Revvity Inc — how do they compare? Equinix Inc trades at $1,027.6 (market cap $99.77B), while Revvity Inc trades at $154.1 (market cap $16.98B). The key difference: Equinix Inc is far larger — about 5.9× Revvity Inc's market cap, and Equinix Inc pays the higher dividend (2.04%). Which is the better fit depends on your goals — on Pluang, investors hold Equinix Inc for 110 Days and Revvity Inc for 12 Days on average.
| EQIX | RVTY | |
|---|---|---|
Market Cap | $99.77B | $16.98B |
Volume | 480,425 | 1,456,900 |
Sector | Real Estate | Health |
52-Week High | $1.12K | $157.36 |
52-Week Low | $726.09 | $82.26 |
Typical Hold Time | 110 Days | 12 Days |
Enterprise Value | $120.90B | $19.30B |
Dividend Yield | 2.04% | 0.18% |
Signals from Pluang's Aura AI — not financial advice
Equinix (EQIX) trades at $1,019.70, down 1.17% on the day, with a bearish technical signal and mixed earnings history including a recent Q2 2026 beat. The company shows strong revenue growth, reaching $9.22B in 2025, and a net income margin of 15.63%, but faces high valuation ratios like a P/E of 65.07. Recent news highlights AI-driven data center demand and a $5B-$7B annual buildout plan, supporting long-term growth prospects amid significant capital expenditures.
The outlook for EQIX is cautiously optimistic, with Wall Street analysts largely bullish (75% buy ratings) and a consensus price target of $1,250 offering ~22% upside. Key risks include elevated debt levels, with debt-to-asset ratio rising to 47.13% in 2025, and sustained negative cash flow from aggressive expansion investments. Investors should weigh strong AI-driven demand against execution risks and high valuation multiples.
RVTY trades at $155.01, up 0.92% with a bullish technical outlook. The stock shows strong earnings momentum with three consecutive quarterly beats and maintains solid profitability with 54.98% gross margins. Recent developments include new product launches in Europe and strategic acquisitions to expand metabolic disease research capabilities.
The investment case balances premium valuation (P/E 73.15) against consistent execution and growth initiatives. Key risks include China market pressures and margin compression, while analyst consensus remains positive with 52% buy ratings. Upside potential exists if Q3 earnings meet expectations in November.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Equinix is a retail provider of data centers, enabling hundreds of enterprise tenants to house their servers and networking equipment in a collocated environment. Tenants can then connect with each other, through cloud service providers and telecom networks. Equinix operates 240 data centers in 66 markets worldwide and owns just less than half of them. The firm has roughly 10,000 customers, including 2,000 networks, that are dispersed over five verticals: Cloud and IT Services, Content Providers, Network and Mobile Services, Financial Services, and Enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from connecting customers with each other. Equinix operates as a real estate investment trust.
Read more on EQIX →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →